American International Group, Inc. 89bio, Inc. Transaction History

American International Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.13 - $13.77 $58,048 - $98,317	7,140 Added 22.43%	38,968 $453,000
Q4 2023 Feb 13, 2024	BUY	$6.66 - $16.03 $6,513 - $15,677	978 Added 3.17%	31,828 $355,000
Q3 2023 Nov 13, 2023	BUY	$15.06 - $19.41 $16,505 - $21,273	1,096 Added 3.68%	30,850 $476,000
Q2 2023 Aug 04, 2023	BUY	$14.15 - $22.03 $421,019 - $655,480	29,754 New	29,754 $563,000
Q2 2022 Aug 12, 2022	SELL	$2.09 - $4.02 $10,238 - $19,693	-4,899 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.45 - $14.99 $1,193 - $5,186	-346 Reduced 6.6%	4,899 $18,000
Q4 2021 Feb 11, 2022	SELL	$11.15 - $19.66 $1,003 - $1,769	-90 Reduced 1.69%	5,245 $69,000
Q3 2021 Nov 12, 2021	SELL	$14.91 - $21.31 $1,893 - $2,706	-127 Reduced 2.33%	5,335 $105,000
Q2 2021 Aug 13, 2021	BUY	$17.42 - $28.0 $10,626 - $17,080	610 Added 12.57%	5,462 $102,000
Q1 2021 May 07, 2021	BUY	$20.22 - $26.73 $262 - $347	13 Added 0.27%	4,852 $115,000
Q4 2020 Feb 12, 2021	BUY	$23.16 - $28.08 $21,886 - $26,535	945 Added 24.27%	4,839 $118,000
Q3 2020 Nov 04, 2020	BUY	$24.34 - $38.82 $50,992 - $81,327	2,095 Added 116.45%	3,894 $100,000
Q2 2020 Aug 12, 2020	BUY	$19.93 - $31.2 $1,195 - $1,872	60 Added 3.45%	1,799 $36,000
Q1 2020 May 04, 2020	SELL	$16.4 - $41.77 $1,639 - $4,177	-100 Reduced 5.44%	1,739 $44,000
Q4 2019 Feb 05, 2020	BUY	$19.75 - $33.44 $36,320 - $61,496	1,839 New	1,839 $48,000

158

108M

73.6K

1.19M

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $387M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.